Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
British Journal of Haematology.
Times cited: 6
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition.
Journal of Experimental Medicine.
Times cited: 92
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Times cited: 77